Sign in with Google. Opens in new tab
ENTITY
Imugene Ltd

Imugene Ltd (IMU AU)

65
Analysis
Health CareAustralia
Imugene Limited is a health biotechnology development company. The Company manufactures vaccines for gastric and breast cancer treatments. Imugene operates in Europe and Australia.
more
bullishImugene Ltd
13 Jan 2025 00:30

Imugene (IMU AU): Pipeline Progresses; Capital Injection to Extend Cash Runway to Late 2025

​Imugene dosed first Australian patient in Phase 1b trial for azer-cel in DLBCL. Azer-cel has potential to become blockbuster drug. Company plans...

Logo
376 Views
Share
20 Jul 2025 00:30

APAC Healthcare Weekly (July 20) – Henlius Bio, CanSino, Nippon Shinyaku, JCR, Mesoblast, Sun Pharma

Henlius Bio initiates P3 U.S. trial for cancer drug. FDA rejected Nippon Shinyaku’s new drug filing. JCR partners with Acumen to develop...

Logo
499 Views
Share
13 Jul 2025 23:00Syndicated

National Storage REIT - The Monday Report - 14 July 2025

Wrap of events affecting the market on Friday night and the weekend and a preview of the week ahead

Logo
FNArena
170 Views
Share
29 Jun 2025 00:30

APAC Healthcare Weekly (June 29)- RemeGen, Innovent, Daiichi, SanBio, Otsuka, Chugai, Glenmark

Last week couple of Chinese companies signed outlicensing deals with international players. Innovent got weight loss drug approval in China....

Logo
483 Views
Share
08 Jun 2025 00:30

APAC Healthcare Weekly (June 8)- Hansoh Pharma, Daiichi Sankyo, Takeda, Mayne Pharma, Zydus Life

Hansoh stuck deal with Regeneron for obesity drug candidate. Daiichi Sankyo unveiled positive phase 3 trial result in first-line breast cancer....

Logo
669 Views
Share
x